News Archive - CureDiab Metabolic Research

Valencia 2023

16. Januar 2023

License contract signed

License contract signed

14. Dezember 2022

CureDiab at the 6th Global NASH Congress

CureDiab at the 6th Global NASH Congress

14. Dezember 2022

alytas therapeutics collaborates with CureDiab

alytas therapeutics collaborates with CureDiab

28. November 2022

New shareholder structure

New shareholder structure

31. August 2022

Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!

Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!

1. Juli 2022